Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dimethyl Sulfate | HCID 6497 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Ammonium Hydroxide | HCID 14923 | — |
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Reactant | HCID 136348430 | HCID 136348430 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Solvent | Oxolane--water (1/1) | HCID 21881883 | — |
| Product | HCID 76287351 | HCID 76287351 | 72% |
Reaction Steps
To 4-(2,4-dichlorophenyl)-1,3,6,6-tetramethyl-4,8-dihydropyrazolo[3,4-e][1,4]thiazepin-7-one (0.150 g, 0.4 mmol, made in the same manner as Preparation C.2) dissolved in THF/H2O (1:1, 10 mL), was added NaOH (0.81 mL, 2 M aqueous). The reaction mixture was stirred for about 24 h at rt. Subsequently, dimethylsulfate (0.077 mL, 0.8 mmol) was added, and the reaction mixture was stirred for about 1 hr at rt. To the reaction mixture was added NH4OH (1 mL, 25% aqueous), followed by 5% aqueous sodium bicarbonate (5 mL) and ethyl acetate (25 mL). The layers were separated and the organic layer was washed with water (25 mL), dried (MgSO4), filtered and concentrated in vacuo. The resulting residue was purified by column chromatography (SiO2, ethyl acetate/DCM (1:9)), to afford 4-(2,4-dichlorophenyl)-1,3,6,6,8-pentamethyl-4H-pyrazolo[3,4-e][1,4]thiazepin-7-one (0.110 g, 0.28 mmol, 72%), as a white solid. LC-MS (Table 1, Method a) Rt=5.05 min, m/z 384 (M+H)+; 1H NMR (400 MHz, CDCl3) δ ppm 1.05 (3 H, br. s.) 1.51 (3 H, br. s.) 2.32 (3 H, br. s.) 2.87 (3 H, br. s.) 3.65 (3 H, br. s.) 5.32 (1 H, br. s.) 7.29 (1 H, dd, J=8.3, 1.9 Hz) 7.34 (1 H, br. s.) 7.72 (1 H, d, J=8.3 Hz).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09150592B2 |
|---|
| Source dataset | uspto-grants-2015_10 |
|---|
| ORD ID | ord-5a66824179f144aaa5234acd400d4e4b |
|---|
| Source note | uspto-grants-2015_10 |
|---|